Purpose: The aim of this study was to evaluate the effect of telerehabilitation-based high intensity interval training (HIIT) on biochemistry parameters and disease symptoms in fibromyalgia patients. Fibromyalgia syndrome (FMS) is a chronic musculoskeletal disease of unknown etiology accompanied by symptoms such as pain, hyperalgesia, sleep disorders, fatigue and mood disorders.
Material and Methods: 33 fibromyalgia patients were randomly assigned as HIIT (n = 11), moderate-intensity continuous training (MICT)(n = 11) and control group (CG)(n = 11). While the patients in the study groups were given upper extremity exercise with telerehabilitation for 6 weeks, no intervention was applied to the CG. Disease symptoms and blood parameters were evaluated before and after treatment.
Results: After the treatment, significant changes were found in the results of superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase GSH(Px), right hand grip strength, pressure pain threshold, fatigue severity and disability in the HIIT group, and in the results of SOD, myeloperoxidase (MPO), left hand grip strength and fatigue severity in the MICT group (p<0 .05). There was a difference in the results of SOD, right hand grip strength, disability, and fatigue severity between the post-treatment groups due to the HIIT group (p<0.05).
Conclusion: HIIT may be an effective treatment choice for patients.
Approval for this study was received from the Clinical Research Ethics Committee of Bakırköy Sadi Konuk Training and Research Hospital.
There is a source of support from Health Sciences University BAP Coordination Unit. Project Number: 2022/043. All authors declare that there is no conflict of interest. The study was carried out in Bakirkoy Dr. Sadi Konuk Training and Research Hospital.
| Primary Language | English |
|---|---|
| Subjects | Pain |
| Journal Section | Research Article |
| Authors | |
| Submission Date | August 18, 2024 |
| Acceptance Date | November 21, 2024 |
| Publication Date | January 31, 2025 |
| Published in Issue | Year 2025 Volume: 9 Issue: 1 |